EQT
45
-3
O
26
-4
KHC
13
-2
MSI
55
-2
F
42
2
ORLY
48
-4
FDX
40
4
LRCX
61
2
VIX
15
7
K
56
3
PNR
62
2
HBI
58
2
CMA
48
2
ADT
32
4
MMM
40
3
MET
60
2
IVZ
50
2
TROW
50
2
KSS
42
3
DG
14
2
EQT
45
-3
O
26
-4
KHC
13
-2
MSI
55
-2
F
42
2
ORLY
48
-4
FDX
40
4
LRCX
61
2
VIX
15
7
K
56
3
PNR
62
2
HBI
58
2
CMA
48
2
ADT
32
4
MMM
40
3
MET
60
2
IVZ
50
2
TROW
50
2
KSS
42
3
DG
14
2
Financhill
Back

Insmed 10K Form

Sell
50

INSM
Insmed

Last Price:
$70.71
Seasonality Move:
7.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09 10Q INSM/Insmed Quarterly
2023-10-26 10Q INSM/Insmed Quarterly
2023-08-03 10Q INSM/Insmed Quarterly
2023-05-04 10Q INSM/Insmed Quarterly
2022-10-27 10Q INSM/Insmed Quarterly
2022-08-04 10Q INSM/Insmed Quarterly

Receive INSM News And Ratings

See the #1 stock for the next 7 days that we like better than INSM

INSM Financial Statistics

Sales & Book Value

Annual Sales: $305.2M
Cash Flow: $-184.6M
Price / Cash Flow: 0
Annual Sales: $2.70
Price / Book: 26.1

Profitability

EPS (TTM): -5.55000
Net Income (TTM): $-864.3M
Gross Margin: $239.6M
Return on Equity: 0%
Return on Assets: -56.29%

Insmed Earnings Forecast

Key Insmed Financial Ratios

  • The Gross Profit Margin over the past 25 years for INSM is 78.52%.
  • The Selling, General & Administrative Expenses for INSM have been equal to 112.87% of Gross Profit Margin.
  • The Research & Development expenses have been 187.09% of Revenue.
  • The Interest Expense is -10.17% of Operating Income.
  • The Net Earning history of INSM is -245.59% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 9 years.

Insmed Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: INSM
CUSIP: 457669
Website: insmed.com

Debt

Debt-to-Equity Ratio: 1.98
Current Ratio: 6.37
Quick Ratio: 5.83

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INSM Technical Analysis vs Fundamental Analysis

Sell
50
Insmed (INSM) is a Sell

Is Insmed a Buy or a Sell?

  • Insmed stock is rated a Sell
    The current Insmed [INSM] share price is $70.67. The Score for INSM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.